☰

Megan M. Durham, M.D. - Publications

Affiliations: 
Emory UniversityChildren's Healthcare of Atlanta, Atlanta 
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Baxter KJ, Srinivasan JK, Ziegler TR, Dhere T, Ricketts RR, Durham MM. Pediatric short bowel syndrome and subsequent development of inflammatory bowel disease: an illustrative case and literature review. Pediatric Surgery International. PMID 28378134 DOI: 10.1007/S00383-017-4080-9  0.32
2007 Kean LS, Adams AB, Strobert E, Hendrix R, Gangappa S, Jones TR, Shirasugi N, Rigby MR, Hamby K, Jiang J, Bello H, Anderson D, Cardona K, Durham MM, Pearson TC, et al. Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression American Journal of Transplantation. 7: 320-335. PMID 17241112 DOI: 10.1111/J.1600-6143.2006.01622.X  0.343
2005 Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, Hagerty D, Townsend R, Hollenbaugh D, Pearson TC, Larsen CP. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. Journal of Immunology (Baltimore, Md. : 1950). 174: 542-50. PMID 15611281 DOI: 10.4049/Jimmunol.174.1.542  0.357
2004 Adams AB, Shirasugi N, Jones TR, Strobert EA, Durham MM, Hollenbaugh D, Hagerty D, Townsend R, Pearson TC, Larsen CP. BLOCKADE OF THE CD40-CD154 PATHWAY USING A CHIMERIC ANTI-HUMAN CD40 MONOCLONAL ANTIBODY SYNERGIZES WITH CD28 BLOCKADE TO PROLONG ISLET ALLOGRAFT SURVIVAL Transplantation. 78: 179-180. DOI: 10.1097/00007890-200407271-00470  0.323
2003 Jones TR, Adams AB, Shirasugi NJ, Bingaman AW, Durham MM, Pearson TC, Larsen CP. Allogeneic parenchymal and hematopoietic tissues differ in their ability to induce deletion of donor-reactive T cells. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 3: 1520-30. PMID 14629282 DOI: 10.1046/J.1600-6135.2003.00262.X  0.345
2003 Adams AB, Shirasugi N, Jones TR, Williams MA, Durham MM, Ha J, Dong Y, Guo Z, Newell KA, Pearson TC, Larsen CP. Conventional immunosuppression is compatible with costimulation blockade-based, mixed chimerism tolerance induction. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 3: 895-901. PMID 12814483 DOI: 10.1034/J.1600-6143.2003.00155.X  0.309
2002 Arbiser JL, Bingaman A, Durham M, Cowan S, Cohen C, Zarnegar E, Varma V, Larsen CP. SVR angiosarcomas can be rejected by CD4 costimulation dependent and CD8 costimulation independent pathways. Molecular Medicine (Cambridge, Mass.). 8: 551-8. PMID 12456994 DOI: 10.1007/Bf03402165  0.325
2002 Williams MA, Onami TM, Adams AB, Durham MM, Pearson TC, Ahmed R, Larsen CP. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. Journal of Immunology (Baltimore, Md. : 1950). 169: 5387-91. PMID 12421910 DOI: 10.4049/Jimmunol.169.10.5387  0.328
2002 Shirasugi N, Adams AB, Durham MM, Lukacher AE, Xu H, Rees P, Cowan SR, Williams MA, Pearson TC, Larsen CP. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. Journal of Immunology (Baltimore, Md. : 1950). 169: 2677-84. PMID 12193741 DOI: 10.4049/Jimmunol.169.5.2677  0.346
2002 Kean LS, Durham MM, Adams AB, Hsu LL, Perry JR, Dillehay D, Pearson TC, Waller EK, Larsen CP, Archer DR. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation. Blood. 99: 1840-9. PMID 11861303 DOI: 10.1182/Blood.V99.5.1840  0.33
2002 Adams AB, Shirasugi N, Durham MM, Strobert E, Anderson D, Rees P, Cowan S, Xu H, Blinder Y, Cheung M, Hollenbaugh D, Kenyon NS, Pearson TC, Larsen CP. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes. 51: 265-70. PMID 11812731 DOI: 10.2337/Diabetes.51.2.265  0.332
2002 Jones TR, Ha J, Williams MA, Adams AB, Durham MM, Rees PA, Cowan SR, Pearson TC, Larsen CP. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts. Journal of Immunology (Baltimore, Md. : 1950). 168: 1123-30. PMID 11801646 DOI: 10.4049/Jimmunol.168.3.1123  0.342
2001 Ha J, Bingaman AW, Durham MM, Pearson TC, Larsen CP. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway Transplant Immunology. 9: 13-17. PMID 11680567 DOI: 10.1016/S0966-3274(01)00043-0  0.345
2001 Williams MA, Tan JT, Adams AB, Durham MM, Shirasugi N, Whitmire JK, Harrington LE, Ahmed R, Pearson TC, Larsen CP. Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. Journal of Immunology (Baltimore, Md. : 1950). 167: 4987-95. PMID 11673506 DOI: 10.4049/Jimmunol.167.9.4987  0.353
2001 Bingaman AW, Ha J, Durham MM, Waitze SY, Tucker-Burden C, Cowan SR, Pearson TC, Larsen CP. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo. Transplantation. 72: 1286-92. PMID 11602857 DOI: 10.1097/00007890-200110150-00018  0.331
2001 Adams AB, Durham MM, Kean L, Shirasugi N, Ha J, Williams MA, Rees PA, Cheung MC, Mittelstaedt S, Bingaman AW, Archer DR, Pearson TC, Waller EK, Larsen CP. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. Journal of Immunology (Baltimore, Md. : 1950). 167: 1103-11. PMID 11441122 DOI: 10.4049/Jimmunol.167.2.1103  0.326
2000 Williams MA, Trambley J, Ha J, Adams AB, Durham MM, Rees P, Cowan SR, Pearson TC, Larsen CP. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. Journal of Immunology (Baltimore, Md. : 1950). 165: 6849-57. PMID 11120808 DOI: 10.4049/Jimmunol.165.12.6849  0.335
2000 Durham MM, Bingaman AW, Adams AB, Ha J, Waitze SY, Pearson TC, Larsen CP. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. Journal of Immunology (Baltimore, Md. : 1950). 165: 1-4. PMID 10861026 DOI: 10.4049/Jimmunol.165.1.1  0.343
2000 Bingaman AW, Ha J, Waitze SY, Durham MM, Cho HR, Tucker-Burden C, Hendrix R, Cowan SR, Pearson TC, Larsen CP. Vigorous allograft rejection in the absence of danger. Journal of Immunology (Baltimore, Md. : 1950). 164: 3065-71. PMID 10706695 DOI: 10.4049/Jimmunol.164.6.3065  0.311
2000 Bingaman AW, Durham MM, Adams AB, Ha J, Pearson TC, Larsen CP. HEMATOPOIETIC CHIMERISM IN THE PRESENCE OF CD40 AND CD28 BLOCKADE LEADS TO PERIPHERAL DELETION OF DONOR REACTIVE T CELLS AND DEVELOPMENT OF DONOR SPECIFIC TRANSPLANTATION TOLERANCE. Transplantation. 69: S240. DOI: 10.1097/00007890-200004271-00495  0.367
1999 Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze SY, Ha J, Durham MM, Corbascio M, Cowan SR, Pearson TC, Larsen CP. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. The Journal of Clinical Investigation. 104: 1715-22. PMID 10606625 DOI: 10.1172/Jci8082  0.35
Show low-probability matches.